NRC (NRC Health Common Stock) Stock Analysis - SEC Filings

NRC Health Common Stock (NRC) is a publicly traded Healthcare sector company. As of May 21, 2026, NRC trades at $19.50 with a market cap of $422.34M and a P/E ratio of 0.38. NRC moved +2.77% today. Year to date, NRC is +2.45%; over the trailing twelve months it is +39.57%. Its 52-week range spans $9.76 to $22.99. Rallies surfaces NRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NRC SEC filings?

Rallies organizes NRC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NRC Key Metrics

Key financial metrics for NRC
MetricValue
Price$19.50
Market Cap$422.34M
P/E Ratio0.38
EPS$50.00
Dividend Yield0.16%
52-Week High$22.99
52-Week Low$9.76
Volume6
Avg Volume0
Revenue (TTM)$137.39M
Net Income$11.60M
Gross Margin61.88%

Latest NRC News

Recent NRC Insider Trades

  • HARRISON SHANE R bought 8.00K (~$98.16K) on Feb 17, 2026.
  • Freeman Jordan Nicole bought 771 (~$10.00K) on Jul 31, 2025.
  • BEANS PATRICK E bought 2.50K (~$33.97K) on May 12, 2025.

NRC Analyst Consensus

NRC analyst coverage data. Average price target: $0.00.

Common questions about NRC

Where can I find NRC SEC filings?
Rallies organizes NRC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NRC 10-K and 10-Q filings?
Rallies organizes NRC SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NRC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NRC. It does not provide personalized investment advice.
NRC

NRC